Literature DB >> 11914298

Commentary: relative treatment effects are consistent across the spectrum of underlying risks...usually.

Finlay A McAlister1.   

Abstract

Mesh:

Year:  2002        PMID: 11914298     DOI: 10.1093/ije/31.1.76

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  13 in total

Review 1.  Frequency of treatment-effect modification affecting indirect comparisons: a systematic review.

Authors:  Michael Coory; Susan Jordan
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Does beta-blocker prophylaxis improve survival after major noncardiac surgery?

Authors:  Marius Terblanche; Neill K J Adhikari; Damon C Scales
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

3.  The "number needed to treat" turns 20--and continues to be used and misused.

Authors:  Finlay A McAlister
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

Review 4.  'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.

Authors:  Andrea Manca; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.

Authors:  Belgin Unal; Julia A Critchley; Dogan Fidan; Simon Capewell
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

6.  Quantitative risk-benefit analysis of natalizumab.

Authors:  J P Thompson; K Noyes; E R Dorsey; S R Schwid; R G Holloway
Journal:  Neurology       Date:  2008-07-29       Impact factor: 9.910

7.  Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.

Authors:  Luigi Palmieri; Kathleen Bennett; Simona Giampaoli; Simon Capewell
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

8.  Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.

Authors:  P McElduff; G Lyratzopoulos; R Edwards; R F Heller; P Shekelle; M Roland
Journal:  Qual Saf Health Care       Date:  2004-06

9.  How the type of risk reduction influences required sample sizes in randomised clinical trials.

Authors:  K Bruynesteyn; A Wanders; R Landewé; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2004-07-01       Impact factor: 19.103

10.  Implementing guidelines in primary care: can population impact measures help?

Authors:  Richard F Heller; Richard Edwards; Patrick McElduff
Journal:  BMC Public Health       Date:  2003-01-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.